跳至主要内容
临床试验/NCT06953648
NCT06953648尚未招募不适用

Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplantation (REMM-HIIT-HCT)

University of Kansas Medical Center6 个研究点 分布在 1 个国家目标入组 126 人开始时间: 2025年5月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
126
试验地点
6
主要终点
Change in Cardiorespiratory Fitness

研究概览

简要总结

The goal of this clinical trial is to learn how a remotely monitored high-intensity interval training (REMM-HIIT) affects the cardiorespiratory fitness and physical function for patients planning to undergo stem cell transplantation. The main questions it aims to answer are:

Is there a change in the participant's cardiorespiratory fitness level? Is there a change in the participant's physical function?

Researchers will compare the REMM-HIIT program to a control group of participants who do not take part in the training program to see if REMM-HIIT helps improve stem cell transplantation outcomes.

Participants will:

  • Complete cardiopulmonary exercise testing (CPET) 4 times during the study
  • Do basic tests to measure physical function 6 times during the study
  • Answer questions about their life and how they are feeling 6 times during the study
  • Wear a device to keep track of step counts and heart rate daily
  • Keep a log of every time they exercise throughout the study
  • Optionally, provide blood and stool samples 6 times during the study

详细描述

Each year in the U.S., approximately 8,000 patients undergo allogeneic hematopoietic stem cell transplantation (HCT) as a potentially curative therapy for leukemias, lymphomas, and other hematologic malignancies. However, treatment-related mortality (TRM) is significant, ranging from 10-30%. Moreover, survivors of HCT often face significant physical, psychological, and social challenges post-treatment, leading to a substantial decrease in quality of life (QOL). Outcomes are closely linked to pre-HCT physical activity and function. For example, patients with worse pre-HCT physical function and capacity have markedly lower one-year survival rates (50% vs. 83%). In contrast, every 50-meter increase in pre-HCT six-minute walk distance (6MWD) correlates with a 9% reduction in relative risk for mortality.

Cardiorespiratory fitness (CRF) is a crucial indicator of physical capacity, reflecting the integrated functioning of the heart, lungs, skeletal muscle, adipose tissue, pancreas, liver and adrenal tissues. While CRF naturally declines with age, this decline is notably accelerated by cancer and its treatments, with cancer patients' average CRF levels comparable to individuals 20-30 years older. Importantly, patients with low pre-HCT CRF (VO2peak <16 mL/kg/min) are at much higher risk of TRM (hazard ratio 6.70), even after accounting for other risk factors. This underscores the critical need for interventions to improve CRF prior to HCT to enhance survival and post-treatment quality of life.

It is well established that patients with better pre-HCT physical function tend to have better post-HCT outcomes. The critical question, however, is whether enhancing fitness pre-HCT can improve post-HCT outcomes. Animal studies provide optimism: exercise training in a murine model pre-HCT associated with improved survival, possibly through immune-mediated pathways. Yet, research exploring the impact of pre-HCT exercise on human post-HCT outcomes remains limited. Small studies have linked pre-HCT improvements in physical function with better survival, and preliminary results from a randomized controlled trial suggest that exercise during HCT may reduce mortality. However, a recent large (n=711) randomized Blood and Marrow Transplant Clinical Trials Network study of self-directed exercise and stress management during HCT did not show a significant benefit in outcomes. Study investigators suggested several reasons for this lack of effect, including timing of intervention (peri-HCT rather than pre-HCT), low intensity rather than high intensity exercise, and low engagement in the self-directed program.

To address prior study limitations, the investigators developed the REMM-HIIT program, focusing on pre-HCT intervention, high-intensity interval training (HIIT), and a mobile health (mHealth) platform to support participant engagement. This program, supported by the National Institute of Aging and the Duke Claude D. Pepper Older Americans Independence Center, was piloted in a successful phase 1 study of Remotely Monitored, Mobile health-supported, pre-HCT High Intensity Interval Training (REMM-HIIT). In this feasibility study, participants underwent baseline cardiopulmonary exercise testing (CPET) to ensure cardiac safety and to measure maximal cardiorespiratory fitness (VO2peak). The heart rate (HR) at VO2peak was used to personalize the high and low intensity interval goals. Participants were equipped with an iPhone and Garmin Watch for remote monitoring and exercised three times a week at home, with the first session and subsequent sessions as needed monitored remotely by the coach via videoconference. This approach ensured continuous support and maximized participant engagement while allowing the majority of sessions to occur remotely.

This program was purposely designed based on investigators' prior research and other significant studies in the field, aiming to overcome common barriers to physical activity in cancer populations. To facilitate participation, the investigators enable exercise at home utilizing the participant's preferred activity (e.g., walking, cycling, stairs) and at convenient times. The majority engaged in walking-based intervention, which despite their simplicity, provided sufficient intensity for deconditioned HCT participants. Others used cycle ergometers. This program adheres to the principles of exercise training and recommendations from Sasso and colleagues, ensuring individualization, progressive overload, appropriate recovery periods, and reasonable specificity. Exercise sessions started with a 5-minute warmup (e.g., walking or cycling at a HR corresponding to 60% VO2peak). This was followed by ten intervals, each consisting of one-minute of high intensity exercise at a HR corresponding to 95% VO2peak, alternated with one minute of low to moderate intensity interval at a HR corresponding to 60% VO2peak, totaling 20 minutes. The session concluded with a 5-minute cooldown, resulting in a comprehensive 30-minutes exercise session. For participants unable to complete all intervals, the study team began with fewer intervals and gradually increased the number as tolerated. A recovery period of 24-48 hours between HIIT sessions was recommended to prevent overtraining and ensure adequate recovery. Broad specificity was achieved by incorporating high, moderate, and low intensity aerobic exercises continuously. As such, the program is a progressive HIIT-based intervention, with flexibility given to ensure the principles of exercise training are upheld, and participants receive the best possible information and guidance to rapidly increase CRF and health outcomes pre-HCT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Plan to undergo allogeneic hematopoietic stem cell transplant in 4-12 weeks after enrollment on this study.
  • Age 18-80 years
  • Able to read/write English (as many participant-reported outcome measures lack validated translations in other languages)

排除标准

  • Unable or unwilling to follow coaching
  • Functional impairment resulting in inability to exercise
  • Any absolute contraindications to exercise:
  • recent (<6 months) acute cardiac event;
  • unstable angina;
  • uncontrolled dysrhythmias causing symptoms;
  • symptomatic aortic stenosis;
  • uncontrolled symptomatic heart failure;
  • acute pulmonary embolus;
  • acute myocarditis or pericarditis;
  • suspected or known dissecting aneurysm

结局指标

主要结局

Change in Cardiorespiratory Fitness

时间窗: At Baseline, Day -10, Day 90, and Day 365

Change in cardiorespiratory fitness as measured by the difference in peak rate of oxygen consumption (VO2peak) in mL/(kg\*min) from baseline to the pre-hematopoietic stem cell transplant (HCT) timepoint; a higher number for VO2 peak indicates greater cardiorespiratory fitness.

Change in Physical Function (Six Minute Walk Test Distance)

时间窗: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365

The change in physical function as measured by the difference in six minute walk test distance in meters from baseline to the pre-hematopoietic stem cell transplantation (HCT) timepoint; a greater number of meters walked indicates a higher level of physical function.

次要结局

  • Effect on Clinical Outcomes (Time to Relapse)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Weight)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Physical Activity/Short Physical Performance Battery)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Physical Activity/30-Second Sit-to-Stand Test)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Physical Activity/Fried Frailty)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Physical Activity/Fall Question)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Physical Activity/Physical Function Questionnaire)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Physical Activity/Fatigue Questionnaire)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Physical Activity/International Physical Activity Questionnaire)(At Baseline)
  • Effect on Health-related Quality of Life (Cognitive/Montreal Cognitive Assessment)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Mental Health/Lorig Self-Efficacy)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Mental Health/Depression Scale)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Mental Health/Anxiety scale)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Albumin Level)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Social Support/Emotional Support)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Return to Work)(At Day 180 and Day 365)
  • Effect on Clinical Outcomes (Overall Survival)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Clinical Outcomes (Treatment-related Mortality)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Clinical Outcomes (Incidence of Infection)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Nutrition)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (Social Support/Social Isolation)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Health-related Quality of Life (EuroQoL-5 Dimension-5 Level)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Effect on Clinical Outcomes (Incidence of Graft-versus-host disease)(At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365)
  • Length of Stay(At day of hospital discharge)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验